Bulevirtide for treatment of patients with HDV infection and compensated cirrhosis: A (huge?) step in the right direction

Liver Int. 2021 Jul;41(7):1441-1442. doi: 10.1111/liv.14967.

Authors

Chiara Masetti¹, Alessio Aghemo^{1

2}

Affiliations

¹ Division of Internal Medicine and Hepatology, Department of Gastroenterology, Humanitas Research Hospital IRCCS, Milan, Italy.
² Department of Biomedical Sciences, Humanitas University, Milan, Italy.

PMID: 34139064
DOI: 10.1111/liv.14967

No abstract available

Publication types

Editorial
Comment

MeSH terms

Hepatitis D* / complications
Hepatitis D* / drug therapy
Hepatitis Delta Virus*
Humans
Liver Cirrhosis / complications
Liver Cirrhosis / drug therapy